{"id":"https://openalex.org/W2000325304","doi":"https://doi.org/10.1002/ddr.10344","title":"Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies","display_name":"Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies","alternate_titles":[],"publication_year":2004,"publication_date":"2004-03-01","ids":{"openalex":"https://openalex.org/W2000325304","doi":"https://doi.org/10.1002/ddr.10344","mag":"2000325304"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.10344","doi":"https://doi.org/10.1002/ddr.10344","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.10344","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000325304"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043951081","display_name":"Reed J. Harris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Reed J. Harris","raw_affiliation_strings":["Analytical Chemistry Department, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Chemistry Department, South San Francisco, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110296609","display_name":"Steven J. Shire","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven J. Shire","raw_affiliation_strings":["Pharmaceutical Research and Development, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research and Development, South San Francisco, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001495870","display_name":"Charles Winter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Winter","raw_affiliation_strings":["Recovery Sciences, Genentech, Inc., South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Recovery Sciences, Genentech, Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043951081"],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":2.1171,"has_fulltext":false,"cited_by_count":211,"citation_normalized_percentile":{"value":0.86550156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"61","issue":"3","first_page":"137","last_page":"154"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.8320000171661377,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.11819999665021896,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0471000000834465,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-concentration-formulations","display_name":"high-concentration formulations","score":0.7839999794960022},{"id":"https://openalex.org/keywords/lyophilized-powder","display_name":"lyophilized powder","score":0.7599999904632568},{"id":"https://openalex.org/keywords/solid-dosage-forms","display_name":"solid dosage forms","score":0.8109999895095825},{"id":"https://openalex.org/keywords/liquid-formulation","display_name":"liquid formulation","score":0.5759999752044678},{"id":"https://openalex.org/keywords/scalable-fabrication","display_name":"scalable fabrication","score":0.5899999737739563},{"id":"https://openalex.org/keywords/analytical-characterization","display_name":"analytical characterization","score":0.6449999809265137},{"id":"https://openalex.org/keywords/molecular-heterogeneity","display_name":"molecular heterogeneity","score":0.7979999780654907},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.6790000200271606},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8360000252723694},{"id":"https://openalex.org/keywords/manufacturing-consistency","display_name":"manufacturing consistency","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7347748279571533},{"id":"https://openalex.org/C72092618","wikidata":"https://www.wikidata.org/wiki/Q894640","display_name":"Vial","level":2,"score":0.5672978758811951},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5391998291015625},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.515235960483551},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.4969315826892853},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4937358796596527},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.46933403611183167},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.45695260167121887},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4044148921966553},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3478527069091797},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22738170623779297},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18325921893119812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16423967480659485},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13951677083969116},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.10344","doi":"https://doi.org/10.1002/ddr.10344","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.10344","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":92,"referenced_works":["https://openalex.org/W208585742","https://openalex.org/W342099418","https://openalex.org/W615944606","https://openalex.org/W1454256324","https://openalex.org/W1482884772","https://openalex.org/W1487765193","https://openalex.org/W1489640652","https://openalex.org/W1493124133","https://openalex.org/W1508836098","https://openalex.org/W1511036913","https://openalex.org/W1514605746","https://openalex.org/W1532634227","https://openalex.org/W1550340517","https://openalex.org/W1569329587","https://openalex.org/W1572633452","https://openalex.org/W1595328377","https://openalex.org/W1700796997","https://openalex.org/W1901412110","https://openalex.org/W1944789189","https://openalex.org/W1965637514","https://openalex.org/W1967096302","https://openalex.org/W1968623409","https://openalex.org/W1969504883","https://openalex.org/W1973199299","https://openalex.org/W1979626824","https://openalex.org/W1982731674","https://openalex.org/W1988377264","https://openalex.org/W1989893455","https://openalex.org/W1997601409","https://openalex.org/W1997999969","https://openalex.org/W2005754127","https://openalex.org/W2006980325","https://openalex.org/W2009238413","https://openalex.org/W2011142709","https://openalex.org/W2011646966","https://openalex.org/W2014959314","https://openalex.org/W2017027704","https://openalex.org/W2017344199","https://openalex.org/W2020975211","https://openalex.org/W2023865852","https://openalex.org/W2025012298","https://openalex.org/W2026823098","https://openalex.org/W2027372351","https://openalex.org/W2030524142","https://openalex.org/W2033417622","https://openalex.org/W2035551749","https://openalex.org/W2044360617","https://openalex.org/W2046766109","https://openalex.org/W2048215036","https://openalex.org/W2055301223","https://openalex.org/W2056509744","https://openalex.org/W2057770903","https://openalex.org/W2059117829","https://openalex.org/W2061153822","https://openalex.org/W2061411952","https://openalex.org/W2061934063","https://openalex.org/W2063234820","https://openalex.org/W2063840206","https://openalex.org/W2066464061","https://openalex.org/W2066856346","https://openalex.org/W2071050148","https://openalex.org/W2073417483","https://openalex.org/W2081874075","https://openalex.org/W2082570714","https://openalex.org/W2082983474","https://openalex.org/W2084136419","https://openalex.org/W2084731542","https://openalex.org/W2089505562","https://openalex.org/W2092638671","https://openalex.org/W2093944762","https://openalex.org/W2118921516","https://openalex.org/W2121107218","https://openalex.org/W2121959405","https://openalex.org/W2123480018","https://openalex.org/W2123984889","https://openalex.org/W2128402413","https://openalex.org/W2129369608","https://openalex.org/W2137354517","https://openalex.org/W2140572194","https://openalex.org/W2147483959","https://openalex.org/W2158649579","https://openalex.org/W2165360511","https://openalex.org/W2262104407","https://openalex.org/W2343891719","https://openalex.org/W2395931478","https://openalex.org/W2408308125","https://openalex.org/W2412877632","https://openalex.org/W2415916271","https://openalex.org/W2419022567","https://openalex.org/W2501195579","https://openalex.org/W4248593773","https://openalex.org/W6715397165"],"related_works":["https://openalex.org/W3132752381","https://openalex.org/W2583879094","https://openalex.org/W2029734945","https://openalex.org/W2015799566","https://openalex.org/W2904122548","https://openalex.org/W3085831021","https://openalex.org/W2095261164","https://openalex.org/W4378530595","https://openalex.org/W7097030987","https://openalex.org/W4378678850"],"abstract_inverted_index":{"Abstract":[0],"Stable":[1],"therapeutic":[2,130],"antibody":[3,28],"dosage":[4,31],"forms":[5],"present":[6],"production":[7],"technology":[8],"challenges,":[9],"particularly":[10],"when":[11],"high\u2010concentration":[12],"formulations":[13,72],"are":[14,23,37,73],"needed":[15],"to":[16,85,93],"meet":[17],"the":[18,53,110],"elevated":[19],"dose":[20],"requirements":[21],"that":[22,119],"generally":[24,38],"required":[25],"for":[26,128],"successful":[27],"therapy.":[29],"Solid":[30],"forms,":[32],"such":[33,105],"as":[34,76,106],"lyophilized":[35],"powders,":[36],"more":[39],"stable":[40],"than":[41,59],"liquid":[42,71],"formulations.":[43],"High\u2010concentration":[44,70],"drug":[45],"products":[46],"can":[47],"be":[48,126],"achieved":[49],"by":[50,102],"reconstitution":[51],"of":[52,112],"lyophilisate":[54],"in":[55],"a":[56,66],"smaller":[57],"volume":[58],"its":[60],"initial":[61],"(pre\u2010lyophilization)":[62],"volume,":[63],"but":[64],"requires":[65],"significant":[67],"vial":[68],"overfill.":[69],"becoming":[74],"feasible":[75],"new":[77],"techniques":[78],"and":[79,109],"technologies":[80],"become":[81],"available.":[82],"Analytical":[83],"methods":[84],"detect":[86],"subtle":[87],"molecular":[88,98],"variations":[89],"have":[90],"been":[91],"developed":[92],"demonstrate":[94],"manufacturing":[95],"consistency.":[96],"Some":[97],"heterogeneity":[99],"is":[100],"contributed":[101],"conserved":[103],"sites,":[104],"Asn297":[107],"glycosylation":[108],"loss":[111],"heavy":[113],"chain":[114],"C\u2010terminal":[115],"Lys":[116],"residues.":[117],"Characteristics":[118],"affect":[120],"potency,":[121],"stability,":[122],"or":[123],"immunogenicity":[124],"must":[125],"elucidated":[127],"each":[129],"antibody.":[131],"Drug":[132],"Dev.":[133],"Res.":[134],"61:137\u2013154,":[135],"2004.":[136],"\u00a9":[137],"2004":[138],"Wiley\u2010Liss,":[139],"Inc.":[140]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000325304","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
